The Food and Drug Administration has recently added a warning to the popular diets drugs, alli® and Xenical®.
Johnson & Johnson strengthened the warnings concerning the risk of suicide with painkillers Ultram and Ultracet after deaths were reported in patients with a history of emotional disturbance or drug and substance abuse. Ultram and Ultracet are indicated for the management of moderate to moderately severe chronic pain. In letters released yesterday by the U.S. Food and Drug Administration ("FDA"), J&J has informed doctors the Prescribing Information for the drugs has been updated to explain that the active ingredient, opioid tramadol, contained within the drugs may be more potent when combined with alcohol, different painkillers or drugs that depress the central nervous system.
The FDA has announced that it is requiring strengthened warnings concerning the possible increased risk of fractures of the hip, wrist, and spine with the use of the class of drugs known as proton pump inhibitors, which includes drugs like Nexium, Prilosec, and Prevacid.
FDA Orders Baxter To Pay Refunds To Purchasers Of its Colleague Volumetric Infusion Pumps: Will You Get Your Refund?
On April 30, 2010, the FDA ordered Baxter Healthcare Corp. to recall and destroy all of its more than 200,000 Baxter Colleague Infusion Pumps due to Baxter’s longstanding failure to correct serious safety problems with the Infusion pumps. These pumps are medical devices designed to deliver fluids, nutrients and medication to patients in a controlled manner. They are widely used by health care practitioners in order to more accurately deliver medications to patients. More than 500 deaths and 56,000 adverse events associated with these infusion pumps have been reported to the FDA in the last five years.
The guidelines of Obama’s new health care law, which prohibit this type of insurance malfeasance, do not take effect until September 23, 2010. So, what better time for Wellpoint to start cancelling policies – before the law becomes the law and after learning that some of its insureds have developed breast cancer. Healthcare reform aims to end this conduct, but it is most certainly bad faith for carriers to cancel coverage of its sickest insureds before it starts in September.
A division of Johnson & Johnson has recalled 43 over-the-counter medicines made for infants and children, including liquid versions of Tylenol, Motrin, Zyrtec and Benadryl, as a result of deficiencies at the company’s manufacturing facility.